ReviewCancers2022
Gene Editing with CRISPR/Cas Methodology and Thyroid Cancer: Where Are We?
Cesar Seigi Fuziwara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ReviewCancers2022
Cesar Seigi Fuziwara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.